Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Supervised Decolonization** was a University of Pennsylvania household decolonization regimen evaluated in the randomized community MRSA-transmission study NCT00966446. It combined intranasal **mupirocin** ointment, administered twice daily for 7 days, with topical **chlorhexidine gluconate** body wash used on days 1 and 7; adherence was supported by daily telephone-call or text-message reminders. Mupirocin inhibits bacterial isoleucyl-tRNA synthetase and suppresses protein synthesis, while chlorhexidine is a membrane-active antiseptic that reduces bacterial burden on the skin. The regimen was studied in households of patients with community-onset methicillin-resistant *Staphylococcus aureus* infection to promote MRSA colonization clearance and reduce household transmission and recurrent skin and soft-tissue infection.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Supervised Decolonization.